Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
Research Funding Statistics
in state funding
in federal funding
In Academic Year 2016, MD Anderson's research expenditure was $787 million. External funding from the state, federal government and our donors provide our faculty with the support needed to conduct breakthrough cancer research and maintain strong educational programs.
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
Jim Allison's Research
Immunotherapy pioneer named among TIME's 100 most influential people
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, the Moon Shots Program™ was launched by MD Anderson as an ambitious plan to make a giant leap in cancer research to benefit patients.Learn more about the Moon Shots Program
Cell therapy research
Advanced lung cancer
RAS mutation research
New treatment strategy
Breast cancer treatment
Revolutionizing lung cancer treatment
Immunotherapy harnesses the power of the immune system to fight cancer and is making an impact on the treatment strategy for many cases of lung cancer. In this episode of Cancer Newsline, John Heymach, M.D., Ph.D., explains why he believes immunotherapy is the future of lung cancer treatment.